SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-20-002644
Filing Date
2020-02-10
Accepted
2020-02-10 08:30:54
Documents
17
Effectiveness Date
2020-02-10

Document Format Files

Seq Description Document Type Size
1 DEFM14A nt10005201x10_defm14a.htm DEFM14A 12131946
2 logo_newlink2.jpg GRAPHIC 58663
3 logo_newlink.jpg GRAPHIC 19282
4 nt10005201x8_annexfheader.jpg GRAPHIC 21006
5 nt10005201x10_graph01.jpg GRAPHIC 142025
6 nt10005201x10_graph02.jpg GRAPHIC 151032
7 nt10005201x10_graph03.jpg GRAPHIC 88248
8 nt10005201x10_graphic01.jpg GRAPHIC 157093
9 nt10005201x10_image01.jpg GRAPHIC 197271
10 nt10005201x10_linechart01.jpg GRAPHIC 44407
11 nt10005201x10_linechart02.jpg GRAPHIC 81992
12 nt10005201x10_linechart03.jpg GRAPHIC 100496
13 nt10005201x10_linechart04.jpg GRAPHIC 118834
14 nt10005201x10_linechart05.jpg GRAPHIC 107964
15 nt10005201x10_proxycards1.jpg GRAPHIC 1608874
16 nt10005201x10_proxycards2.jpg GRAPHIC 878647
17 sig_kpmgllp2.jpg GRAPHIC 10075
  Complete submission text file 0001140361-20-002644.txt   17177879
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35342 | Film No.: 20589688
SIC: 2834 Pharmaceutical Preparations